Cocaine Hydrochloride Patent Expiration
Cocaine Hydrochloride is Used for local anesthesia in patients with uveal melanoma and hepatic metastases, as well as those with hepatic or renal impairment. It was first introduced by Noden Pharma Dac
Cocaine Hydrochloride Patents
Given below is the list of patents protecting Cocaine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Goprelto | US10016407 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10149843 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10231961 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10413505 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10420760 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10857095 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10894012 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10933060 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10973811 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US10987347 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US11040032 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Goprelto | US9867815 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Noden Pharma |
| Numbrino | US10016407 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10149843 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10231961 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10413505 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10420760 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10857095 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10894012 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10933060 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US10973811 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US11040032 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
| Numbrino | US9867815 | Pharmaceutical compositions and methods of using the same | Feb 07, 2037 | Omnivium Pharms |
Cocaine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List